Gene Query: LZIC

Dataset Description Geneva Score
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 13.89
HNRNPL and its RNA Targets in Prostate Cancer 12.52
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 12.52
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 11.76
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 9.89
The Human Testis Cell Atlas via Single-cell RNA-seq 9.18
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.17
Cleavage Factor Im as a key regulator of 3’ UTR length 9.14
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.04
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.87
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 8.42
FBXW7 modulates stress response by post-translational modification of HSF1 8.41
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 8.41
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 7.67
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 7.67
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.53
LNCaP treated with iBET 7.45
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.43
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.16
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.02
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 6.42
RNA sequencing of primary human platelets and in vitro cell lines 6.31
Neonatal and adult human testis defined at the single-cell level 6.16
Global analysis of enhancer targets: Mosaic-seq 5.98
Cellular response to hepatitis E virus (HEV) infection 5.87
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.84
RNA-seq analyisis of PUM2 knockout cells 5.83
hnRNP C is a key regulator of protein synthesis in mitosis 5.66
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 5.52
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 5.48
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.38
RNAseq Analysis in glioblastoma cells treated with Mepazine 5.36
Short and Long RNA sequencing of human mature erythrocytes 5.3
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.16
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.15
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.15
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 5.05
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.05
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 5.04
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 4.98
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.98
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.92
Effect of CHKA knockdown on C4-2 cell transcriptome 4.89
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 4.73
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 4.71
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.71
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.66
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.51
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.5
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.5
SLIGRL-induced gene expression changes in NHEK cells 4.41
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.36
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.34
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.34
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.24
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 4.22
SUV420H2 knockdown in PANC-1 4.13
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 4.07
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.04
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.04
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 4.04
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.0
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.93
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.93
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 3.92
Nutritional control of protein translation 3.77
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.76
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.73
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.73
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.72
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.71
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.66
CROP-Seq in Primary Human T Cells 3.65
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.64
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.62
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.61
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 3.6
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 3.59
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 3.59
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.54
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.53
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.52
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.52
Transcriptional profile in human S. haematobium infection 3.47
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.43
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.42
ChIP-seq and RNA-seq from human lymphoma cell lines 3.34
RNA-seq data from human lymphoma cell lines 3.34
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 3.33
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 3.31
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.3
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.29
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.24
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.19
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.17
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 3.12
Ribosomal footprinting of MDA-Parental and MDA-LM2 3.1
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.09
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.09
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.07
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.07
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.03
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.02
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.01
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.99
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 2.98
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 2.98
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 2.94
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.9
TT-Seq captures the human transient transcriptome 2.9
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.9
Single-nucleotide-resolution mapping of HBV promoters using CAGE 2.89
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.86
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.86
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 2.85
Transcriptome sequencing of K-562 cells 2.84
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.82
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.82
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 2.81
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 2.81
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.8
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.8
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.78
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 2.73
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 2.73
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.73
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.73
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.68
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 2.67
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.67
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 2.65
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.64
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.6
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.6
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.57
Identification of renal resident macrophages across species 2.57
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.56
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.56
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 2.56
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.55
IMP3 regulated gene expression in breast cancer cells 2.54
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 2.54
Identifying the molecular mode of action of itraconazole in colorectal cancer 2.54
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 2.53
Accurate annotation of human protein-coding small open reading frames 2.51
Ribosomal footprinting of CN34-Parental and CN34-LM1a 2.51
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.49
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.49
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.49
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.46
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 2.46
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 2.45
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.44
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.43
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 2.42
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.4
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 2.39
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.38
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.38
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.38
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.38
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.38
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.36
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.35
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 2.35
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.31
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 2.29
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.29
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.26
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 2.26
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.25
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.25
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.24
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 2.22
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 2.22
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.22
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 2.22
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 2.19
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.17
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 2.17
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.16
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.16
Global Mapping of Human RNA-RNA Interactions 2.15
The conserved transcriptional landscapes in human spermatogenesis 2.15
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.14
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 2.14
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.14
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.12
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.12
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.11
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 2.11
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.11
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.1
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.1
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 2.1
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.1
Transcriptomic analyssis following EHMT1/2 inhibition 2.09
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 2.09
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.09
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.09
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.09
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 2.09
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.06
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.04
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 2.02
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.01
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.99
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 1.99
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.98
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.96
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 1.96
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.95
Global analysis of alternative splicing regulated by RBM10 1.94
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.94
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 1.93
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 1.92
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.91
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.91
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.91
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.91
RNA-seq in transgenic cells 1.89
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.87
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.86
Gene expression changes caused by KRAS in MCF-10A 1.86
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.86
Single-Cell Genotyping of Transcriptomes 1.86
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.86
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.85
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.85
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.85
Identification of a LIF-responsive replication-competent human β cell 1.82
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 1.81
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.79
The bromodomain protein BRD4 regulates splicing during heat shock 1.78
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.78
Gene expression analysis in response to hypoxic pathway inhibition 1.76
LncRNA expression profiling of ischemic stroke patients 1.75
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 1.74
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 1.74
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.74
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.74
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.71
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.71
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.71
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 1.71
HEK293 TFAM Knockout Expression Study 1.7
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.7
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.69
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.68
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.66
Gene expression profile in breast cancer cells 1.66
Induced DNA demethylation, genome instability and transcription 1.66
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.66
Downregulation of DDX5/DDX17 and REST 1.65
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.65
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.64
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.64
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.64
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.64
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.63
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.62
Novel Targeting of Transcription and Metabolism in Glioblastoma 1.61
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.61
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.6
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.6
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 1.6
Role of COP1 on MAP kinase transcriptional output in melanoma 1.6
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.59
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.59
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.59
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.57
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.57
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.53
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.53
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.51
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.51
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.5
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 1.49
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.49
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.48
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.48
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.48
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.48
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.47
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.46
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.46
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.45
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.44
Knockdown of ADNP in HCT116 colon cancer cells 1.44
STX4 Over-Expression in Human islets 1.42
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.42
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.42
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.41
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.4
Transcription control by the ENL YEATS domain in acute leukemia 1.4
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 1.39
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 1.39
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.39
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.38
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.38
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.37
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.36
Cajal bodies are linked to genome conformation 1.34
Cajal bodies are linked to genome conformation [RNA-Seq] 1.34
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 1.34
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 1.33
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.33
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.33
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.29
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.29
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.28
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.28
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.28
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.26
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.23
RNA expression analysis upon JMJD1C depletion 1.23
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.22
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 1.22
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.21
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.21
Transposon-based construction of strand-specific RNA-seq libraries 1.2
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.19
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.19
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.18
PRDM1 inhibits proliferation of human colon cancer organoids 1.16
Global transcriptome analysis of HAP1 cells 1.15
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 1.15
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.14
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.13
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.13
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.12
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.11
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.1
scRNASeq analysis of cycling cardiomyocytes 1.09
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.07
Genome-wide discovery of human splicing branchpoints [RNAse] 1.06
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 1.05
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.05
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 1.02
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 1.02
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.01
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.0
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.99
Functional significance of the HIV-1 Tat signature amino acid residues 0.99
JAK dependent survival of ALK- ALCL 0.99
0.98
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.97
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.97
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.97
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.96
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.96
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.94
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.94
Transcriptional landscape changes during human embryonic stem cell derivation 0.94
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.93
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.92
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.92
Gene expression signatures of innate lymphoid cells from human blood 0.91
Clinker: visualizing fusion genes detected in RNA-seq data 0.9
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.89
Oncogenic roles of ARID5B in T-ALL 0.89
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.88
Expression profiling of etoposide-induced senescent cells 0.87
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.87
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.86
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.83
SLAM-seq for K562 endogenous mRNA decay 0.82
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.82
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.8
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.79
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.78
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.78
Genome-wide analysis of the Integrator complex 0.78
Genome-wide analysis of the Integrator complex (HTS) 0.78
Single-cell analysis of human kidney organoids 0.75
O-glcnAc reprograms cellular energetics 0.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.75
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.75
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.72
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.71
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.71
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 0.7
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.68
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.68
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.68
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.67
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.67
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.67
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.66
RNA editing in nascent RNA affects pre-mRNA splicing 0.66
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.65
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.63
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.63
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.62
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.61
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.61
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.61
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.61
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.6
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.59
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.59
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.58
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 0.58
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 0.58
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.58
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.57
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.56
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.56
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.56
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.55
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.55
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.55
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.55
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.55
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.55
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.54
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.54
K562 polyA RNA-Seq 0.53
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.53
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.52
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.51
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.51
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.5
Human Treg IFNg/IL-10 subpopulations 0.5
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.49
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.49
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.49
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.48
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.48
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.48
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.47
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.44
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.43
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.43
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.43
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.41
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.41
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.41
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.39
Discovering human diabetes-risk gene function with genetics and physiological assays 0.38
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.38
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.37
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.37
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 0.37
Human Treg NaCl stimulation 0.37
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.37
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.37
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.36
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.36
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.36
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.35
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.35
quanTIseq: quantifying immune contexture of human tumors 0.35
HBEC-shp53-PCHD7 0.35
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.34
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.34
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.32
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.32
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.3
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.28
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.26
FOXP1 orchestration of ASD-relevant signaling pathways. 0.22
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.22
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.22
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.22
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.21
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.2
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.2
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.19
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.19
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.17
SOX11 knockdown in B-ALL cell lines 0.16
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.16
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.16
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.16
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.15
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.15
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.15
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.12
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.12
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.1
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.1
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.09
mRNA-Seq profiling of human developing kidney 0.08
Modulation of nonsense-mediated decay by rapamycin 0.07
Ribosomal protein RPL26 is the principal target of UFMylation 0.06
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.06
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.05
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.03
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.03
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.03
The cohesin complex prevents Myc-induced replication stress 0.03
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.02
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.01
p53 activity results in DNA replication fork processivity 0.01
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation